| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.048 | 0.7 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |